1. Orphanet J Rare Dis. 2020 Jul 8;15(1):180. doi: 10.1186/s13023-020-01425-5.

Exome sequencing for diagnosis of congenital hemolytic anemia.

Mansour-Hendili L(1)(2), Aissat A(3)(4), Badaoui B(5), Sakka M(3)(4), Gameiro 
C(3), Ortonne V(3), Wagner-Ballon O(4)(5), Pissard S(3)(4), Picard V(6), Ghazal 
K(7), Bahuau M(3), Guitton C(8), Mansour Z(9), Duplan M(10), Petit A(11), 
Costedoat-Chalumeau N(12), Michel M(4)(13), Bartolucci P(4)(13)(14), Moutereau 
S(3)(4), Funalot B(3)(4), Galactéros F(4)(13)(14).

Author information:
(1)Département de Biochimie-Biologie Moléculaire, Pharmacologie, Génétique 
Médicale, AP-HP, Hôpitaux Universitaires Henri Mondor, F-94010, Creteil, France. 
lamisse.mansour-hendili@aphp.fr.
(2)Univ Paris Est Creteil, INSERM, IMRB, F-94010, Creteil, France. 
lamisse.mansour-hendili@aphp.fr.
(3)Département de Biochimie-Biologie Moléculaire, Pharmacologie, Génétique 
Médicale, AP-HP, Hôpitaux Universitaires Henri Mondor, F-94010, Creteil, France.
(4)Univ Paris Est Creteil, INSERM, IMRB, F-94010, Creteil, France.
(5)Département d'hématologie et d'immunologie, AP-HP, Hôpitaux Universitaires 
Henri Mondor, F-94010, Creteil, France.
(6)Département d'hématologie, AP-HP, Hôpital Bicêtre, F-94270, Le 
Kremlin-Bicêtre, France.
(7)Département de Biochimie, AP-HP, Hôpital Bicêtre, F-94270, Le 
Kremlin-Bicêtre, France.
(8)Département d'hématologie pédiatrique, AP-HP, Hôpital Bicêtre, F-94270, Le 
Kremlin-Bicêtre, France.
(9)Clinique ADASSA, Maternité, F-67000, Strasbourg, France.
(10)Département d'onco-hématologie pédiatrique, CHU d'Angers, 4 Rue Larrey, 
49100, Angers, France.
(11)Département d'onco-hématologie pédiatrique, AP-HP, Hôpital Armand Trousseau, 
F-75012, Paris, France.
(12)Département de médecine interne, AP-HP, Hôpital Cochin, F-75014, Paris, 
France.
(13)Département de médecine interne, AP-HP, Hôpitaux Universitaires Henri 
Mondor, F-94010, Creteil, France.
(14)Unité des maladies génétiques du globule rouge (UMGGR), AP-HP, Hôpitaux 
Universitaires Henri Mondor, F-94010, Creteil, France.

BACKGROUND: Congenital hemolytic anemia constitutes a heterogeneous group of 
rare genetic disorders of red blood cells. Diagnosis is based on clinical data, 
family history and phenotypic testing, genetic analyses being usually performed 
as a late step. In this study, we explored 40 patients with congenital hemolytic 
anemia by whole exome sequencing: 20 patients with hereditary spherocytosis and 
20 patients with unexplained hemolysis.
RESULTS: A probable genetic cause of disease was identified in 82.5% of the 
patients (33/40): 100% of those with suspected hereditary spherocytosis (20/20) 
and 65% of those with unexplained hemolysis (13/20). We found that several 
patients carried genetic variations in more than one gene (3/20 in the 
hereditary spherocytosis group, 6/13 fully elucidated patients in the 
unexplained hemolysis group), giving a more accurate picture of the genetic 
complexity of congenital hemolytic anemia. In addition, whole exome sequencing 
allowed us to identify genetic variants in non-congenital hemolytic anemia genes 
that explained part of the phenotype in 3 patients.
CONCLUSION: The rapid development of next generation sequencing has rendered the 
genetic study of these diseases much easier and cheaper. Whole exome sequencing 
in congenital hemolytic anemia could provide a more precise and quicker 
diagnosis, improve patients' healthcare and probably has to be democratized 
notably for complex cases.

DOI: 10.1186/s13023-020-01425-5
PMCID: PMC7341591
PMID: 32641076 [Indexed for MEDLINE]

Conflict of interest statement: No competing of interests.